Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T31425 |
Dibenz[a,h]anthracene
CCRIS 208,二苯葸,NSC 22433,AI3-18996,DB(a,h)A |
DNA | DNA Damage/DNA Repair |
Dibenz[a,h]anthracene (CCRIS 208) 诱导细菌DNA 损伤和基因突变,并在几种哺乳动物细胞培养物中诱导基因突变和转化。 | |||
T75766 |
GP(33-41) TFA
|
||
GP(33-41) TFA 是一种由 9 个氨基酸残基组成的多肽,它是淋巴细胞性脉络丛脑膜炎病毒 GP1 抗原决定基中的序列。GP(33-41) TFA 能够上调 RMA-S (Db Kb) 细胞表面 H-2Db 分子,SC50值为 344 nM。 | |||
TP1752 |
GP(33-41)
|
||
GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus, and can upregulate H-2Db molecules at the RMA-S (Db Kb) cell surface with a SC50 of 344 nM. GP33-41 Epitopeis a strong agonist of CD8 T cells | |||
T35800 |
MD001
|
||
MD001 is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ.1 It binds to PPARα and PPARγ (Kds = 9.55 and 0.14 μM, respectively) but does not bind to PPARβ/δ at concentrations up to 500 μM. It increases transcriptional activity of PPARα and PPARγ in a cell-based luciferase reporter assay when used at a concentration of 10 μM. MD001 (10 μM) increases expression of PPARα, PPARγ, and retinoid X receptor (RXR), as well as PPARα and PPARγ target genes, in HepG2 cells. It... |